THE
concept that the administration of sex hormones could prevent pregnancy when administered after coitus is far from new. In the first attempts to develop emergency contraception, relatively large amounts of oestro gen were administered to cause withdrawal bleed ing after suspension of treatment. The effect of oestrogen is to cause the endometrium, the mem brane that lines the interior of the uterus, to grow. The fall in the concentration of oestrogen in the blood then causes the endometrial lining to be sloughed off, with consequent bleeding. gesterone, produced by the ovary after ovulation, transform the endometrium, making it receptive to the fertilised egg. This progesterone-induced effect was to be countered by the administration of a large amount of oestrogen, thus prevent ing implantation. However, the high amount of oestrogen that was used caused nausea and vomiting in almost every subject, leading to the abandonment of the idea.1 '2 This early research was the origin of the concept that any post-coital pill for pregnancy prevention that is taken after sexual intercourse acts by preventing implantation. The fact is,
however, that the current dedicated emergency contraception pill is a progestogen, a hormone that induces changes in the endometrium nec essary for the maintenance of pregnancy. This fact has not changed the popular belief that the mechanism of action of all emergency con traceptive pills is to block implantation. That mistaken belief is coupled with the lack of understanding that the female oocyte is not fertilised immediately after intercourse; fertil isation may occur from 24 hours to five days later, giving time to interfere with the process before fertilisation. This misconception may be irrelevant in most of the world, but it has been a key element on which a concerted attack against free access to emergency contraception pills in Latin America has been based. The lack of aware ness of the political implications of the belief that emergency contraception prevents implan tation may be the reason why so little care has been taken to correct this misconception.
Emergency contraceptive pill and its mechanism of action Widespread knowledge of emergency contra ception is relatively new, but the first clinical trials showing it was possible to control human fertility by the administration of steroidal hor mones after coitus were published 40 years ago.1 Several options were tried, from high doses of oestrogen alone, as described above, to high doses of combined oral pills containing ethinyl oestradiol and levonorgestrel, known as the Yuzpe regime.4-6 In 1974, these authors gave the name "morning-after pill' to this method, intended to be used following rape or unex pected and unprotected sexual intercourse. One year earlier Kesseru et al had proposed the use of levonorgestrel alone as a post-coital pill, to be taken after every sexual intercourse during the cycle, a scheme with the theoretical advantage of not requiring a daily pill.7 The effectiveness of this method was much lower than that of the combined pill, so its use was discouraged. In fact, there is an almost total lack of reference to it even in some of the most comprehensive books on contraception pub lished before the mid-1990s.
It Initially, efforts to make emergency contra ception accessible to women were focused on the Yuzpe regimen, since it used four tablets of the standard contraceptive pill, which contained 250 meg of levonorgestrel and 50 meg of ethinyl oestradiol, which was readily available in many countries. The woman had to take two of these pills as soon as possible and no later than 72 hours after unprotected sexual intercourse, and another two pills 12 hours later. In theory, access to the Yuzpe regimen was relatively easy. In practice, its use was minimal because know ledge of it was limited among both the public and gynaecologists.10,11 pills, which meant that the number of pills to be taken to obtain the right dose increased to eight, four as soon as possible and four 12 hours later. As the general public were not aware of the dif ferent doses of hormones in different brands of pills, they had difficulty in knowing how many pills to take post-coitally. In the absence of a dedi cated product, that became an obstacle to more widespread use of this kind of contraception. a high level of acceptance of emergency contra ception was expected. It is a region where a large power imbalance between the sexes still exists and it is not uncommon for women to be exposed to unexpected, undesired and unpro tected intercourse, which is when the greatest benefit of emergency contraception is obtain able. It is also a region with very restrictive abortion laws, where women only exceptionally have access to safe, legal abortion, even if they fulfill the legal conditions, and where most of those with unwanted pregnancies end up having unsafe abortions.
The need for emergency contraception exists worldwide. The logical conclusion is therefore that women should have access to such a prod uct. However, in spite of the potential market for levonorgestrel emergency contraceptive pills, none of the large pharmaceutical companies has shown any interest in producing and dis tributing it, apparently to avoid the political opposition to emergency contraception that has been observed for the last decade.
Confronted with this resistance, the Consor tium for Emergency Contraception played a key role in Latin America by working with local and international NGOs to motivate smaller phar maceutical firms to produce a dedicated prod uct in practically every country in the region. The best known and first to be marketed was Postinor-2, distributed with that brand name in several countries in the region.
The pattern of opposition
Shortly after efforts to disseminate information more widely about emergency contraception started, and when dedicated products began to appear from 1997 on, strong opposition from the Catholic church hierarchy emerged. Their opposition is posited on the belief that emer gency contraception prevents implantation of the fertilised egg and that the fertilised egg has the same rights as a living person. Consequently, using emergency contraception is equivalent to killing a human being or, at the least, the same tries, is never the end of the story. If its oppo nents lose the battle against registration and approval of the method, then they try to ban its distribution or limit sales by requiring a phy sician's prescription. If the government decides to make it accessible to everyone through the public clinics, by including it alongside the other available contraceptive methods, initia tives to ban its availability are immediately begun. Their allies at all levels of service pro vision are urged to limit access to it, both nation ally and locally, with any success depending on the extent of their political influence. This has been an apparently endless struggle that has at least temporarily limited access to emergency contraception in several countries, including Chile, Peru, Argentina and Colombia.28 Yet there is practically no opposition to the Yuzpe regimen, which is the only emergency contraception available in Panama, Costa Rica and Honduras.
In countries where no dedicated emergency contraceptive pill is registered, the Catholic church has not acted to prevent access to the combined pill being used also as emer gency contraception in the public health service, maybe because it is never as widely used as when a dedicated product exists. Although there were a few public statements from the hierarchy of the Catholic church against emergency contraception, one leading liberal bishop declared to the press that it was better to use emergency contraception after coercive unprotected sex than having an unwanted preg nancy that would be aborted. Feminist groups did not play an important role, probably because it was not required, but also because they showed a certain mistrust of emergency contraception at that early period. Currently, emergency contra ception is sold widely over the counter in pharmacies and distributed throughout the public health system, although logistic problems prevent it always being available. egg. The Constitutional Court decided not to consider the issue of whether emergency contra ception was abortifacient but ruled that the Minister did not have authority to decide to make it available by decree, only the President. Soon after, President Bachelet signed a decree with the full support of the scientific and academic community, as well as from women's groups, sup porting provision of emergency contraception. Although this is an important success, the situation is far from resolved. Since October 2006, all pharmaceutical companies registered in Chile to sell emergency contraception stopped marketing the product. The Ministry of Health is now looking for a pharmaceutical firm willing to produce emergency contraception. The only one to date that agreed to do so changed its mind under pressure from a pro-life consumer group. Thus, the only product available comes from APROFA, the national family planning association and an IPPF affiliate, that sells one brand at a relatively low price, and the remain ing stock of the Ministry of Health.
Throughout this period the strongest defender of emergency contraception was ICMER. The Ministry of Health was supportive most of the time. APROFA and the women's Network for Sexual and Reproductive Health and Rights also played an important role.
At the present time, conservative groups remain very active and have considerable financial sup port. The down side is that there is no emergency contraception product sold in pharmacies. On the positive side, there is finally unanimity among scientific and academic institutions in publicly defending the notion that emergency contra ception is not abortifacient and should be avail able to everyone, to help to ensure the right of women to decide about their own fertility.
Current situation in Latin America
A dedicated emergency contraceptive product is registered and marketed in almost every country in the Latin American region except Panama, Costa Rica, Honduras and Guatemala. Although in Mexico and Argentina a medical prescrip tion is in theory required, in most pharmacies women can get a packet without a prescription.
Most governments have included emergency contraceptive pills among the methods recom mended in their family planning guidelines and several have made emergency contraception avail able through the public health system, including Mexico, Peru, Chile, Uruguay, Nicaragua and Brazil. The actual availability of the method at basic health posts is a different matter, more dependent on the logistic capacity of the local government health management than of an intended policy, at least in the countries just mentioned.
In some countries, emergency contra ception is not freely distributed to everyone who requests it through the public health system, but is limited to cases of rape, such as in Guatemala.
A positive consequence of the publicity pro vided by the public opposition of the Catholic Church is that awareness of the concept and the actual method of emergency contraception has grown, and emergency contraception has become widely used. In Mexico, for example, it is estimated that about 1. The cost of one packet of emergency contra ceptive pills is US$ 5-7 in most countries in the region. This is barely affordable for most women, and probably not affordable at all for poorer and younger women, thus creating a serious barrier to access. That is why its free distribution as part of national family planning and reproductive health programmes is so important and also why the opposition is so determined to block this hap pening. For the time being, we are very far from universal access to emergency contraception, which is a shameful example of the violation of the rights of women in the Latin American region.
The future
It is impossible to predict the future, but it is always possible to have hope and a goal. Sin embargo, la aeumulacion de evidencia es que el mecanismo de action de la anticoncepcion de emergencia es impedir la ovulation y que esta no interfiere con la implantation. El movimiento contra el derecho a decidir ha hecho caso omiso de esto. El patron de oposicion a la anticoncepcion de emergencia ha sido el mismo en toda la region de Latinoamerica. La profesion medica y la sociedad civil, incluido el Consorcio International sobre Anticoncepcion de Emergencia, han desempefiado un papel importante en defensa del acceso a la anticoncepcion de emergencia en toda la region. Una consecuencia positiva de la oposicion ptiblica de la Iglesia catolica es que el concepto y el metodo ahora son mas conocidos y el uso de la anticoncepcion de emergencia es muy extendido.
Los casos de Peru, Brasil y Chile se describen como ejemplos.
